Home Neon Therapeutics

Neon Therapeutics

acquired
IPO
Clinical-Stage Biopharmaceutical Company
Basic
Enterprise Profile

Basic Information

Neon Therapeutics is a clinical-stage biopharmaceutical company. It focuses on the field of neoantigen-targeted therapies and is committed to transforming cancer treatment by directing the immune system toward neoantigens. The company's pipeline products include NEO-PV-01, NEO-PTC-01, and NEO-SV-01.
Neon Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2015
info@neontherapeutics.com

Enterprise Profile

Industrial Sector
Immune Cell Therapy Biological Drug Production
Technology
Targeted Technology Immunological Techniques Cell Technology
Concept
Tumor
Application Scenarios
Traditional Vaccines (Biological Products for Prevention) Cell and Gene Therapy